ZCM
ALPN

Ziegler Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ziegler Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$951K Buy
23,982
+1,599
+7% +$47.2K 0.04% 282
2023
Q4 		$427K Buy
+22,383
New +$311K 0.02% 363

Other funds holding ALPN

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Ziegler Capital Management's ALPN Position: Q1 2024 in Review

Ziegler Capital Management increased its Alpine Immune Sciences Inc (ALPN) stake by 7.1% in Q1 2024, buying an estimated $47.2K and bringing the position to 23,982 shares worth $951K. The position accounts for 0.04% of the portfolio, ranked #282.

Ziegler Capital Management first reported a position in ALPN in Q4 2023 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold ALPN as of Q1 2024.

  • Ziegler Capital Management held 23,982 shares of Alpine Immune Sciences Inc worth $951K as of Q1 2024.
  • Ziegler Capital Management bought 1,599 Alpine Immune Sciences Inc shares in Q1 2024, an estimated $47.2K.
  • Alpine Immune Sciences Inc made up 0.04% of Ziegler Capital Management's portfolio in Q1 2024, its #282 holding.
  • Ziegler Capital Management first reported a position in Alpine Immune Sciences Inc in Q4 2023 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.